ИНТЕРМЕДИАТЫ КАТАБОЛИЗМА ПУРИНОВ ПРИ РАКЕ МОЛОЧНОЙ ЖЕЛЕЗЫ
Аннотация
Заболеваемость раком молочной железы занимает второе место в общей структуре онкопатологии среди женщин и характеризуется ежегодным увеличением новых выявленных случаев. Одним из перспективных направлений является исследование роли пуриновых нуклеотидов и интермедиатов их катаболизма. В последнее время стали обсуждать взаимосвязь между метаболизмом пуринов и прогрессированием рака. Выдвигается предположение, что продукты катаболизма пуринов могут играть важную роль в развитии и прогрессировании онкопатологии.
Ключевые слова
пурины,
сүт безі обыры,
аденин,
гуанин,
ксантин,
гипоксантин,
пурины,
рак молочной железы,
аденин,
гуанин,
ксантин,
гипоксантин
Список литературы
1. Влияние метформина на метаболизм пуринов при раке молочной железы /О. П. Шатова, Е. В. Бутенко, Е. В. Хомутов и др. // Биомедицинская химия. - 2016. - №62, Вып. 3. -С. 302-305.
2. Динамика показателей пуринового обмена в плазме и эритроцитах крови у больных раком почки /Е. М. Франциянц, И. В. Каплиева, С. Н. Димитриади //Соврем. Проблемы науки и образования. - 2015. - №5.; URL:http://www.science-education.ru/ru/article/view?id=21444.
3. Alka S. Purine-benzimidazole hybrids: Synthesis, single crystal determination and in vitro evaluation of antitumor activities /S. Alka, L. Vijay, P. Kamaldeep //European Journ. of Medicinal Chemistry. - 2015. - V. 93. - P. 414-422.
4. Borowiec A. Adenosine as a metabolic regulator of tissue function: production of adenosine by cytoplasmic 5'-nucleotidases /A. Borowiec, K. Lechward, K. Tkacz-Stachowska //Acta Biochimica Polonica. - 2006. - V. 53. - P. 269-278.
5. Chan C. Y. Microtubule-directed transport of purine metabolons drives their cytosolic transit to mitochondria /C. Y. Chan, A. M. Pedley, D. Kim //Proc. Natl. Acad. Sci. - 2018. -V. 18. - P. 13009-13014.
6. Chan C. Y. Purinosome formation as a function of the cell cycle /C. Y. Chan, H. Zhao, R. J. Pugh //Proc. Natl. Acad. Sci. - 2015. - V. 3. -P. 1368-1373.
7. Di Virgilio F. Extracellular purines, purinergic receptors and tumor growth /F. Di Virgilio, E. Adinolfi //Oncogene. - 2018. - V. 36. -Р. 293-303.
8. Eltzschig H. K. Neutrophils as sources of extracellular nucleotides: functional consequences at the vascular interface /H. K. Eltzschig, C. F. Macmanus, S. P. Colgan //Trends Cardio-vasc. Med. - 2008. - V. 18. - P. 103-107.
9. Extracellular Nucleic Acids and Purine Bases in blood of patients with locally Invasive breast carcinoma /V. B. Sirota, L. E. Muravlyova, R. E. Bakirova, //World Journal of Medical Sciences. - 2014. - V. 11(2). - P. 171-174.
10. Fredholm B. B. Adenosine, an endogenous distress signal, modulates tissue damage and repair //Cell Death Differ. - 2007. - V. 14. -P. 1315-1323.
11. Fredholm B. B. Aspects of the general biology of adenosine A2A signaling /B. B. Fredholm, Y. Chern et al. //Prog. Neurobiol. -2007. - V. 83. - P. 263-276.
12. Global cancer statistics /A. Jemal, F. Bray, M. M. Center //CA Cancer Journal for Clinicians. - 2011. - V. 61. - P. 69-90.
13. Gorlach A. Control of Adenosine Transport by Hypoxia //Circulation Research. -2005. - V. 97. - P. 1-3.
14. Hasko G. Adenosine: an endogenous regulator of innate immunity / G. Hasko, B. N. Cronstein //Trends Immunol. - 2004. - V. 25. -P. 33-39.
15. Increased Risk of Cancer in relation to Gout: A Review of Three Prospective Cohort Studies with 50,358 Subjects /W. Wang, D. Xu, B.Wang //Mediators of Inflammation. - 2015. -Article ID 680853, 6 pages http://dx.doi.org/10.1155/2015/680853.
16. Integrated transcriptomic and metabolomic analysis shows that disturbances in metabolism of tumor cells contribute to poor survival of RCC patients /P. Poptawski, T. Tohge, J. Bogustawska et al. //Biochim. Biophys. Acta Mol. Basis Dis. - 2017. - V. 1863. - P. 744-752.
17. Jain M. Metabolite Profiling Identifies a Key Role for Glycine in Rapid Cancer Cell Proliferation /M. Jain, R. Nilsson, S. Sharma et al. //Sci-Science. - 2012. - V. 336. - P. 1040-1044.
18. Katherine M. Aird, Rugang Zhang Nucleotide metabolism, oncogene-induced senescence and cancer //Cancer Letters. - 2015. - V. 356. - P. 204-210.
19. Kyoung M. Dynamic architecture of the purinosome involved in human de novo purine biosynthesis /M. Kyoung, S. J. Russell, C. L. Kohnhorst //Biochemistry. - 2015. - V. 54. - P. 870-880.
20. Lazarowski E. R. Vesicular and conductive mechanisms of nucleotide release // Purinergic Signal. - 2012. - V. 8. - P. 359-373.
21. Lee Y. The purine scaffold Hsp90 inhibitor PU-H71 sensitizes cancer cells to heavy ion radiation by inhibiting DNA repair by homologous recombination and non-homologous end joining / Y. Lee, H. K. Li, A. Masaoka //Radiotherapy and Oncology. - 2016. - V. 121. - P. 162-168.
22. Lohman A. W. Mechanisms of ATP release and signalling in the blood vessel wall /A. W. Lohman, M. Billaud, B. E. Isakson // Cardiovasc. Res. - 2012. - V. 95. - P. 269-280.
23. Mechanisms of ATP Release by Inflammatory Cells /M. Dosch, J. Gerber, F. Jebbawi et al. //Int. J. Mol. Sci. - 2018. - V. 19. - pii: E1222.
24. Mehrmohamadi M. Characterization of the usage of the serine metabolic network in human cancer /M. Mehrmohamadi, X. Liu, A. A. Shestov // Cell Rep. - 2014. - V. 9. - P. 1507-1519.
25. Metabolomic alterations in invasive ductal carcinoma of breast: A comprehensive metabolomic study using tissue and serum samples /T. H. More, R. S. Choudhury, J. Christie, K. Taunk // Oncotarget. - 2017. - V. 9. - P. 2678-2696.
26. Pedley A. M. A New View into the Regulation of Purine Metabolism: The Purinosome /A. M. Pedley, S. J. Benkovic //Trends Biochem. Sci. -2017. - V. 42. - P. 141-154.
27. Praetorius H. A. ATP release from nonexcitable cells /H. A. Praetorius, J. Leipziger // Purinergic Signal. - 2009. - V. 5. - P. 4433-4464.
28. Purine Nucleotide Biosynthesis Enzyme Guanosine Monophosphate Reductase Is a Suppressor of Melanoma Invasion /J. A. Wawrzyniak, A. B. Smiraglia, W. Bshara. - 2013. - V. 5. - P. 493-507.
29. Role of adenosine signaling in the pathogenesis of breast cancer /A. Bahreyni, S. S. Samani, F. Rahmani //J. Cell Physiol. - 2018. - V. 233. - P. 1836-1843.
30. Serum uric acid and risk of cancer mortality in a large prospective male cohort /A. M. Strasak, K. Rapp, W. Hilbe //Cancer Causes and Control. - 2007. - V. 18. - P.1021-1029.
31. Tedeschi P. M. Contribution of serine, folate and glycine metabolism to the ATP, NADPH and purine requirements of cancer cells /P. M. Tedeschi, E. K. Markert, M. Gounder //Cell Death. Dis. - 2013. - V. 4: e877.
32. Whiteside T. L. Targeting adenosine in cancer immunotherapy: a review of recent progress //Expert Rev. Anticancer Ther. - 2017. - V. 17 (6). - P. 527-535.
33. Wikoff W. R. Metabolomic markers of altered nucleotide metabolism in early stage adenocarcinoma /W. R. Wikoff, D. Grapov, J. F. Fahrmann //Cancer Prev. Res. - 2015. - V. 8. - P. 410-418.
34. Xuebao W. Design, synthesis and ability of non-gold complexed substituted purine derivatives to inhibit LPS-induced inflammatory response / W. Xuebao, H. Chao, W. Kaiqi //European Journ. of Medicinal Chemistry. - 2018. - V. 149. - P. 10-21.
35. Yegutkin G. G. Nucleotide- and nucleoside-converting ectoenzymes: important modulators of purinergic signalling cascade //Biochim. Biophys. Acta. - 2008. - V. 1783. - P. 673-694.
36. Zhao A. Revisiting and revising the purinosome /A. Zhao, M. Tsechansky, A. D. Ellington // Mol. Biosyst. - 2014. - V. 10. - P. 369-374.
37. Zhao H. The purinosome, a multiprotein complex involved in the de novo biosynthesis of purines in humans /H. Zhao, J. B. French, Ye. Fang //Chem. Commun. - 2013. - V. 18. - c3cc41437j.
Рецензия
Для цитирования:
Жумакаева С.С. ИНТЕРМЕДИАТЫ КАТАБОЛИЗМА ПУРИНОВ ПРИ РАКЕ МОЛОЧНОЙ ЖЕЛЕЗЫ. Медицина и экология. 2019;(4):5-10.
For citation:
Zhumakayeva S.S. PURINE CATABOLISM INTERMEDIATES IN BREAST CANCER. Medicine and ecology. 2019;(4):5-10. (In Russ.)
Просмотров: 135
Послать статью по эл. почте 